Amphastar Pharmaceuticals's market cap is currently $1.48B. The company's EPS TTM is $3.005; its P/E ratio is 10.38; Amphastar Pharmaceuticals is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $0.94. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 644.39M	$ 498.99M	$ 437.77M	$ 349.85M	$ 322.36M
Gross Profit	$ 351.12M	$ 248.86M	$ 199.74M	$ 143.34M	$ 131.92M
Operating Income	$ 196.99M	$ 78.76M	$ 43.13M	$ -14.23M	$ -39.00K
EBITDA	$ 240.29M	$ 107.50M	$ 111.78M	$ 30.19M	$ 81.47M
Net Income	$ 137.54M	$ 91.39M	$ 62.12M	$ 1.10M	$ 48.94M
Balance Sheet
Cash & Short-Term Investments	$ 256.81M	$ 175.76M	$ 136.67M	$ 105.62M	$ 85.36M
Total Assets	$ 1.51B	$ 741.99M	$ 671.53M	$ 631.24M	$ 586.97M
Total Debt	$ 623.64M	$ 102.58M	$ 104.66M	$ 67.27M	$ 66.63M
Net Debt	$ 479.35M	$ -53.52M	$ -21.69M	$ -25.37M	$ -7.06M
Total Liabilities	$ 873.49M	$ 213.33M	$ 226.01M	$ 182.51M	$ 159.44M
Stockholders' Equity	$ 639.42M	$ 528.66M	$ 445.52M	$ 402.31M	$ 381.37M
Cash Flow
Free Cash Flow	$ 145.34M	$ 65.15M	$ 70.54M	$ 23.41M	$ 207.00K
Operating Cash Flow	$ 183.50M	$ 89.18M	$ 97.99M	$ 57.27M	$ 41.76M
Investing Cash Flow	$ -649.12M	$ -32.78M	$ -28.67M	$ -36.41M	$ -50.53M
Financing Cash Flow	$ 454.09M	$ -26.44M	$ -37.02M	$ -2.25M	$ -3.78M

Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History

Income Statement >

Amphastar Pharmaceuticals Debt to Assets

Balance Sheet >

Amphastar Pharmaceuticals Cash Flow

Cash Flow >

Amphastar Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing